Skip to main content

Peer Review reports

From: Pre-treatment metastatic growth rate is associated with clinical outcome in patients with metastatic renal cell carcinoma treated with nivolumab

Original Submission
6 Aug 2022 Submitted Original manuscript
18 Sep 2022 Reviewed Reviewer Report - Akihiko Matsumoto
26 Sep 2022 Reviewed Reviewer Report
9 Oct 2022 Reviewed Reviewer Report - Gabriele Pezone
27 Mar 2023 Author responded Author comments - Taigo Kato
Resubmission - Version 2
27 Mar 2023 Submitted Manuscript version 2
10 Apr 2023 Reviewed Reviewer Report - Gabriele Pezone
12 Apr 2023 Reviewed Reviewer Report - Akihiko Matsumoto
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
14 Apr 2023 Editorially accepted
10 Jun 2023 Article published 10.1186/s12894-023-01248-z

You can find further information about peer review here.

Back to article page